Asimov is a biotech company that specializes in research and development of gene therapies. In addition to the therapies it researches, Asimov provides a technology platform that scientists and geneticists can utilize to research prospective genetic treatments. The private company’s platform contains a genetic informational library and design software for simulation of synthetic biological processes.

Register for Details

For more details on financing and valuation for Asimov, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Asimov's ticker symbol?

Asimov does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Asimov's stock price?

The stock price for Asimov will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Asimov's major investors?

Casdin Capital
Fidelity Management and Research Company
AME Cloud Ventures
Canada Pension Plan Investment Board
Horizons Ventures
DCVC

Asimov Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/5/2023 Series B and B-1 $200MM raised $XXX.XX $XXX.XX
6/30/2020 Series A and A-1 $37.1MM raised $XXX.XX $XXX.XX
5/15/2017 Series Seed $4.7MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Asimov

Forge green plus iconForge green minus icon

What is Asimov funding to date?

Asimov has raised $241.8MM to date.
Forge green plus iconForge green minus icon

When was Asimov founded?

Asimov was founded in 2017.
Forge green plus iconForge green minus icon

Can you invest in Asimov?

Asimov is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Asimov share pre-IPO?

If you own Asimov pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Asimov a publicly traded company?

Asimov is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Asimov in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: Jan 5, 2023